FRA:BAYN - Bayer Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
€103.50 +1.54 (+1.51 %)
(As of 05/25/2018 06:52 AM ET)
Previous Close€101.96
Today's Range€102.44 - €103.92
52-Week Range€91.58 - €123.82
Volume941,014 shs
Average VolumeN/A
Market Capitalization$78.80 billion
P/E RatioN/A
Dividend Yield2.93%
BetaN/A

About Bayer (FRA:BAYN)

Bayer logoBayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, and cosmetics in the dermatology, nutritional supplement, analgesic, digestive health, allergy, cold, foot care, and sun protection categories. The Crop Science segment offers crop protection products, seeds, non-agriculture pest control products. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to vets, farmers, and pet-owners. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Receive BAYN News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
SymbolFRA:BAYN
CUSIPN/A
Phone+49-214-301

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares826,950,000

Bayer (FRA:BAYN) Frequently Asked Questions

What is Bayer's stock symbol?

Bayer trades on the FRA under the ticker symbol "BAYN."

What price target have analysts set for BAYN?

22 brokerages have issued 1 year target prices for Bayer's stock. Their forecasts range from €94.00 to €140.00. On average, they expect Bayer's stock price to reach €118.29 in the next twelve months. View Analyst Ratings for Bayer.

Who are some of Bayer's key competitors?

Who are Bayer's key executives?

Bayer's management team includes the folowing people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 56)
  • Mr. Johannes M. Dietsch, Head of Fin. Dept, CFO - Asia/Pacific Region & Member of Management Board (Age 56)
  • Mr. Liam Condon, CEO of Bayer Cropscience & Member of Management Board (Age 50)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 56)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 62)

Has Bayer been receiving favorable news coverage?

News stories about BAYN stock have been trending somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Bayer earned a news impact score of 0.24 on Accern's scale. They also gave news articles about the healthcare company an impact score of 48.29 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

What is Bayer's stock price today?

One share of BAYN stock can currently be purchased for approximately €103.84.

How big of a company is Bayer?

Bayer has a market capitalization of $78.80 billion.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, LEVERKUSEN, 51373, Germany. The healthcare company can be reached via phone at +49-214-301.


MarketBeat Community Rating for Bayer (BAYN)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  1,038 (Vote Outperform)
Underperform Votes:  755 (Vote Underperform)
Total Votes:  1,793
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bayer (FRA:BAYN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
22 Wall Street analysts have issued ratings and price targets for Bayer in the last 12 months. Their average twelve-month price target is €118.29The high price target for BAYN is €140.00 and the low price target for BAYN is €94.00. There are currently 1 sell rating, 6 hold ratings and 15 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.642.642.622.62
Ratings Breakdown: 1 Sell Rating(s)
6 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: €118.29€118.62€122.55€123.30

Bayer (FRA:BAYN) Consensus Price Target History

Price Target History for Bayer (FRA:BAYN)

Bayer (FRA:BAYN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
5/4/2018Deutsche BankReiterated RatingBuyView Rating Details
5/3/2018Nord/LBSet Price TargetNeutral€94.00View Rating Details
5/3/2018Goldman Sachs GroupSet Price TargetBuy€125.00View Rating Details
5/3/2018UBSSet Price TargetBuy€120.00View Rating Details
5/3/2018equinetSet Price TargetBuy€118.00View Rating Details
5/3/2018Independent ResearchSet Price TargetNeutral€102.00View Rating Details
5/3/2018JPMorgan Chase & Co.Set Price TargetBuy€122.00View Rating Details
5/3/2018CommerzbankSet Price TargetBuy€111.00View Rating Details
5/3/2018Baader BankSet Price TargetBuy€140.00View Rating Details
5/3/2018Warburg ResearchSet Price TargetNeutral€120.00View Rating Details
5/3/2018Sanford C. BernsteinSet Price TargetBuy€123.00View Rating Details
5/3/2018Berenberg BankSet Price TargetNeutral€118.00View Rating Details
4/30/2018BarclaysSet Price TargetSell€95.00View Rating Details
4/13/2018Jefferies GroupSet Price TargetBuy€119.00View Rating Details
4/10/2018CfraSet Price TargetBuy€110.00View Rating Details
3/16/2018Kepler Capital MarketsSet Price TargetNeutral€104.00View Rating Details
3/2/2018DZ BankReiterated RatingBuyView Rating Details
2/16/2018CitigroupReiterated RatingBuyView Rating Details
11/14/2017Societe GeneraleSet Price TargetNeutral€117.00View Rating Details
10/26/2017S&P GlobalSet Price TargetBuy€126.00View Rating Details
9/25/2017BNP ParibasSet Price TargetBuy€130.00View Rating Details
6/12/2017Bank of AmericaSet Price TargetBuy€140.00View Rating Details
11/9/2016Bankhaus LampeSet Price TargetBuy€103.00View Rating Details
(Data available from 5/25/2016 forward)

Earnings

Dividends

Bayer (FRA:BAYN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Bayer (FRA BAYN) Insider Trading and Institutional Ownership History

Insider Trading History for Bayer (FRA:BAYN)

Bayer (FRA BAYN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Bayer (FRA BAYN) News Headlines

Source:
DateHeadline
Bayer Awards Grants to Patient Caregiver and Hemophilia ResearchersBayer Awards Grants to Patient Caregiver and Hemophilia Researchers
www.prnewswire.com - May 22 at 4:25 PM
Buffetts Berkshire increases Monsanto stake as Bayer acquisition nears completionBuffett's Berkshire increases Monsanto stake as Bayer acquisition nears completion
www.bizjournals.com - May 21 at 4:26 PM
Global Isocyanates Procurement Market Intelligence Report 2018 with BASF, DowDuPont, Bayer, Asahi Kasei, and ...Global Isocyanates Procurement Market Intelligence Report 2018 with BASF, DowDuPont, Bayer, Asahi Kasei, and ...
www.businesswire.com - May 18 at 4:35 PM
Bayer Fungicide Solution Celebrates Nine Consecutive Years as a Top-Performing Program in University TrialsBayer Fungicide Solution Celebrates Nine Consecutive Years as a Top-Performing Program in University Trials
www.prnewswire.com - May 15 at 4:48 PM
Feed a Bee program commits additional $250000 in forage grant initiatives across the countryFeed a Bee program commits additional $250000 in forage grant initiatives across the country
www.prnewswire.com - May 15 at 10:00 AM
Bayer (BAYN) Receives Consensus Recommendation of "Buy" from AnalystsBayer (BAYN) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 14 at 9:28 PM
Does Bayer Aktiengesellschaft’s (FRA:BAYN) Debt Level Pose A Problem?Does Bayer Aktiengesellschaft’s (FRA:BAYN) Debt Level Pose A Problem?
finance.yahoo.com - May 10 at 4:36 PM
Former Bayer CEOs tech firm moving to RIDC Parkway WestFormer Bayer CEO's tech firm moving to RIDC Parkway West
www.bizjournals.com - May 8 at 4:27 PM
Coppertone® Launches the Protect What Matters Most Initiative to Empower Kids to Rethink Sun Safety and Take ActionCoppertone® Launches the Protect What Matters Most Initiative to Empower Kids to Rethink Sun Safety and Take Action
www.prnewswire.com - May 7 at 4:37 PM
Monsanto CEO Grant to make way for Bayers Condon post-takeoverMonsanto CEO Grant to make way for Bayer's Condon post-takeover
finance.yahoo.com - May 7 at 4:37 PM
[$$] Monsanto CEO to Leave After Sale to Bayer[$$] Monsanto CEO to Leave After Sale to Bayer
finance.yahoo.com - May 7 at 4:37 PM
Monsanto Departures Mark End of Era With Bayer Deal ImminentMonsanto Departures Mark End of Era With Bayer Deal Imminent
finance.yahoo.com - May 7 at 4:37 PM
Monsanto CEO and others to leave after Bayer takeoverMonsanto CEO and others to leave after Bayer takeover
finance.yahoo.com - May 7 at 4:37 PM
BRIEF-Bayer Announces Executive Leadership Team For New Crop Science DivisionBRIEF-Bayer Announces Executive Leadership Team For New Crop Science Division
www.reuters.com - May 7 at 9:16 AM
Bayer (BAYN) Earns Buy Rating from Deutsche BankBayer (BAYN) Earns Buy Rating from Deutsche Bank
www.americanbankingnews.com - May 4 at 10:06 AM
Bayer (BAYN) PT Set at €94.00 by Nord/LBBayer (BAYN) PT Set at €94.00 by Nord/LB
www.americanbankingnews.com - May 3 at 11:43 PM
Goldman Sachs Analysts Give Bayer (BAYN) a €125.00 Price TargetGoldman Sachs Analysts Give Bayer (BAYN) a €125.00 Price Target
www.americanbankingnews.com - May 3 at 11:43 PM
Bayer (BAYN) Given a €120.00 Price Target by UBS AnalystsBayer (BAYN) Given a €120.00 Price Target by UBS Analysts
www.americanbankingnews.com - May 3 at 6:46 PM
Bayer (BAYN) PT Set at €102.00 by Independent ResearchBayer (BAYN) PT Set at €102.00 by Independent Research
www.americanbankingnews.com - May 3 at 6:46 PM
Bayer (BAYN) PT Set at €118.00 by equinetBayer (BAYN) PT Set at €118.00 by equinet
www.americanbankingnews.com - May 3 at 6:46 PM
Bayer (BAYRY) Misses Earnings and Revenue Estimates in Q1Bayer (BAYRY) Misses Earnings and Revenue Estimates in Q1
www.nasdaq.com - May 3 at 4:24 PM
Bayer trades flat even after cutting full-year earnings guidanceBayer trades flat even after cutting full-year earnings guidance
seekingalpha.com - May 3 at 4:24 PM
Bayer (BAYN) Given a €118.00 Price Target at Berenberg BankBayer (BAYN) Given a €118.00 Price Target at Berenberg Bank
www.americanbankingnews.com - May 3 at 12:06 PM
Sanford C. Bernstein Analysts Give Bayer (BAYN) a €123.00 Price TargetSanford C. Bernstein Analysts Give Bayer (BAYN) a €123.00 Price Target
www.americanbankingnews.com - May 3 at 12:06 PM
Bayer (BAYN) PT Set at €140.00 by Baader BankBayer (BAYN) PT Set at €140.00 by Baader Bank
www.americanbankingnews.com - May 3 at 10:12 AM
Bayer (BAYN) PT Set at €120.00 by Warburg ResearchBayer (BAYN) PT Set at €120.00 by Warburg Research
www.americanbankingnews.com - May 3 at 10:12 AM
Bayer (BAYN) PT Set at €122.00 by JPMorgan ChaseBayer (BAYN) PT Set at €122.00 by JPMorgan Chase
www.americanbankingnews.com - May 3 at 10:12 AM
Bayer (BAYN) Given a €111.00 Price Target at CommerzbankBayer (BAYN) Given a €111.00 Price Target at Commerzbank
www.americanbankingnews.com - May 3 at 10:12 AM
BRIEF-Bayer CEO Says We Dont Expect Any More Major DivestmentsBRIEF-Bayer CEO Says We Don't Expect Any More Major Divestments
www.reuters.com - May 3 at 9:21 AM
Barclays Reiterates "€95.00" Price Target for Bayer (BAYN)Barclays Reiterates "€95.00" Price Target for Bayer (BAYN)
www.americanbankingnews.com - April 30 at 8:25 AM
Bayer (BAYN) Given a €125.00 Price Target at Goldman SachsBayer (BAYN) Given a €125.00 Price Target at Goldman Sachs
www.americanbankingnews.com - April 27 at 1:04 PM
Bayer (BAYN) Given a €120.00 Price Target at Warburg ResearchBayer (BAYN) Given a €120.00 Price Target at Warburg Research
www.americanbankingnews.com - April 26 at 10:32 AM
Bayer (BAYN) PT Set at €120.00 by Deutsche BankBayer (BAYN) PT Set at €120.00 by Deutsche Bank
www.americanbankingnews.com - April 24 at 12:16 PM
JPMorgan Chase Analysts Give Bayer (BAYN) a €122.00 Price TargetJPMorgan Chase Analysts Give Bayer (BAYN) a €122.00 Price Target
www.americanbankingnews.com - April 24 at 9:12 AM
Bayer (BAYN) Given a €120.00 Price Target at UBSBayer (BAYN) Given a €120.00 Price Target at UBS
www.americanbankingnews.com - April 23 at 10:24 AM
UBS Analysts Give Bayer (BAYN) a €125.00 Price TargetUBS Analysts Give Bayer (BAYN) a €125.00 Price Target
www.americanbankingnews.com - April 20 at 3:01 PM
Bayer (BAYN) Given a €125.00 Price Target at UBSBayer (BAYN) Given a €125.00 Price Target at UBS
www.americanbankingnews.com - April 20 at 10:45 AM
Bayer (BAYN) PT Set at €124.00 by Deutsche BankBayer (BAYN) PT Set at €124.00 by Deutsche Bank
www.americanbankingnews.com - April 19 at 8:00 PM
Bayer AG (BAYN) Receives Consensus Recommendation of "Buy" from BrokeragesBayer AG (BAYN) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - April 19 at 7:21 PM
Bayer Earns National Recognition as Diversity and Inclusion Leader in Americas 2018 "Best-of-the-Best" CorporationsBayer Earns National Recognition as Diversity and Inclusion Leader in America's 2018 "Best-of-the-Best" Corporations
www.prnewswire.com - April 19 at 4:38 PM
Commerzbank Analysts Give Bayer (BAYN) a €111.00 Price TargetCommerzbank Analysts Give Bayer (BAYN) a €111.00 Price Target
www.americanbankingnews.com - April 17 at 8:27 AM
Baader Bank Reiterates "€140.00" Price Target for Bayer (BAYN)Baader Bank Reiterates "€140.00" Price Target for Bayer (BAYN)
www.americanbankingnews.com - April 17 at 8:05 AM
Bayer (BAYN) Given "Buy" Rating at Deutsche BankBayer (BAYN) Given "Buy" Rating at Deutsche Bank
www.americanbankingnews.com - April 17 at 8:05 AM
Bayer (BAYN) PT Set at €125.00 by Goldman SachsBayer (BAYN) PT Set at €125.00 by Goldman Sachs
www.americanbankingnews.com - April 16 at 10:54 PM
Singapores Temasek buys 3.6 percent Bayer stake in capital increaseSingapore's Temasek buys 3.6 percent Bayer stake in capital increase
www.reuters.com - April 16 at 4:25 PM
Singapores Temasek hikes Bayer stake in $3.7 billion share saleSingapore's Temasek hikes Bayer stake in $3.7 billion share sale
finance.yahoo.com - April 16 at 4:25 PM
Argus Downgrades Monsanto After DOJ Blesses Bayer MergerArgus Downgrades Monsanto After DOJ Blesses Bayer Merger
finance.yahoo.com - April 16 at 4:25 PM
Bayer (BAYN) Given a €122.00 Price Target at JPMorgan ChaseBayer (BAYN) Given a €122.00 Price Target at JPMorgan Chase
www.americanbankingnews.com - April 16 at 7:03 AM
Bayer (BAYN) PT Set at €126.00 by CommerzbankBayer (BAYN) PT Set at €126.00 by Commerzbank
www.americanbankingnews.com - April 15 at 5:39 PM
Bayer (BAYN) Given a €120.00 Price Target by Independent Research AnalystsBayer (BAYN) Given a €120.00 Price Target by Independent Research Analysts
www.americanbankingnews.com - April 15 at 5:06 PM

SEC Filings

Bayer (FRA:BAYN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Bayer (FRA BAYN) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.